RT Journal Article
SR Electronic
T1 Confidence in visual detection, familiarity and recollection judgements is preserved in schizophrenia spectrum disorder
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.03.28.23287851
DO 10.1101/2023.03.28.23287851
A1 Rouy, Martin
A1 Pereira, Michael
A1 Saliou, Pauline
A1 Sanchez, Rémi
A1 el Mardi, Wassila
A1 Sebban, Hanna
A1 Baqué, Eugénie
A1 Dezier, Childéric
A1 Porte, Perrine
A1 Micaux, Julia
A1 de Gardelle, Vincent
A1 Mamassian, Pascal
A1 Moulin, Chris J.A.
A1 Dondé, Clément
A1 Roux, Paul
A1 Faivre, Nathan
YR 2023
UL http://medrxiv.org/content/early/2023/03/29/2023.03.28.23287851.abstract
AB An effective way to quantify metacognitive abilities is to ask participants to estimate their confidence in the accuracy of their response during a cognitive task. A recent meta-analysis1 raised the issue that most assessments of metacognitive abilities in schizophrenia spectrum disorders may be confounded with cognitive deficits, which are known to be present in this population. Therefore, it remains unclear whether the reported metacognitive deficits are metacognitive in nature, or rather inherited from cognitive deficits. Arbitrating between these two possibilities requires equating task performance between experimental groups. Here, we aimed to characterize metacognitive performance among individuals with schizophrenia across three tasks (visual detection, familiarity, recollection) using a within-subject design, while controlling experimentally for intra-individual task performance and statistically for between-subject task performance. In line with our hypotheses, we found no metacognitive deficit for visual detection and familiarity judgements. While we expected metacognition for recollection to be specifically impaired among individuals with schizophrenia, we found evidence in favor of an absence of a deficit in that domain also. The clinical relevance of our findings is discussed in light of a hierarchical framework of metacognition.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the European Research Council (ERC) under the European Union s Horizon 2020 research and innovation programmAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee Sud Mediterranee II gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced are available online at https://gitlab.com/nfaivre/metaface_scz_public https://osf.io/k4p79